Skip to main content
Erschienen in:

27.01.2022 | Original article

Behaviour modification intervention for patients with chronic kidney disease could provide a mid- to long-term reduction in public health care expenditure: budget impact analysis

verfasst von: Reiko Okubo, Masahide Kondo, Shu-Ling Hoshi, Hirayasu Kai, Chie Saito, Kunitoshi Iseki, Chiho Iseki, Tsuyoshi Watanabe, Ichiei Narita, Seiichi Matsuo, Hirofumi Makino, Akira Hishida, Kunihiro Yamagata

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

A recent cost-effectiveness analysis (CEA) study evaluated the widespread diffusion of behaviour modification intervention for patients with chronic kidney disease (CKD). Incorporating this behaviour modification intervention, comprising educational sessions on nutrition/lifestyle and support for regular patient visits, to the current CKD guideline-based practice was found to be cost-effective. This study aimed to examine the affordability of this efficient new practice under the hypothesis that the behaviour modification intervention would be initiated by general physicians (GPs).

Methods

A budget impact analysis was conducted by defining the target population as patients aged 40–74 years with stage-3–5 CKD based on the prevalence of definitive CKD in the Japanese general population. Costs expended by social insurers without discount were counted as budgets. We estimated the annual budget impact for 15 years by running our CEA model, assuming that it would be good for the span.

Results

We estimated the number of patients with end-stage kidney disease (ESKD) to decrease by 4,496 in the fifteenth year of the new practice using our CEA model. Compared to that in the current practice, the budget impact as total additional expenditure of the new practice was estimated to be negative by the tenth year in the base case.

Conclusions

The widespread diffusion of behaviour modification intervention would contain public health care expenditure over the mid-to-long term, resulting from a reduction in progression to ESKD. We suggest that providing sufficient economic incentives to GPs and strengthening recommendations in CKD guidelines would realise effective GP-initiated interventions.
Literatur
1.
Zurück zum Zitat Nagai K, Asahi K, Iseki K, Yamagata K. Estimating the prevalence of definitive chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2021;25:885–92.CrossRef Nagai K, Asahi K, Iseki K, Yamagata K. Estimating the prevalence of definitive chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2021;25:885–92.CrossRef
2.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRef
3.
Zurück zum Zitat Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.CrossRef Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.CrossRef
4.
Zurück zum Zitat Yamagata K, Makino H, Akizawa T, et al. Design and methods of a strategic outcome study for chronic kidney disease: frontier of renal outcome modifications in Japan. Clin Exp Nephrol. 2010;14:144–51.CrossRef Yamagata K, Makino H, Akizawa T, et al. Design and methods of a strategic outcome study for chronic kidney disease: frontier of renal outcome modifications in Japan. Clin Exp Nephrol. 2010;14:144–51.CrossRef
5.
Zurück zum Zitat Yamagata K, Makino H, Iseki K, et al. Effect of behavior modification on outcome in early- to moderate-stage chronic kidney disease: a cluster-randomized trial. PLoS ONE. 2016;11:e0151422.CrossRef Yamagata K, Makino H, Iseki K, et al. Effect of behavior modification on outcome in early- to moderate-stage chronic kidney disease: a cluster-randomized trial. PLoS ONE. 2016;11:e0151422.CrossRef
6.
Zurück zum Zitat Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1–15.CrossRef Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1–15.CrossRef
7.
Zurück zum Zitat Kai H, Saito C, Yamagata K. Attempt to introduce a nutrition care station from the activities of FROM-J for prevention of severe renal disease. Medicica 2012:1880–3. Kai H, Saito C, Yamagata K. Attempt to introduce a nutrition care station from the activities of FROM-J for prevention of severe renal disease. Medicica 2012:1880–3.
9.
Zurück zum Zitat Japanese Society of Nephrology Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Tokyo: Tokyo Igakusha; 2012. Japanese Society of Nephrology Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Tokyo: Tokyo Igakusha; 2012.
10.
Zurück zum Zitat Okubo R, Kondo M, Hoshi SL, et al. Cost-effectiveness of behavior modification intervention for patients with chronic kidney disease in the FROM-J study. J Ren Nutr. 2021;31:484–93.CrossRef Okubo R, Kondo M, Hoshi SL, et al. Cost-effectiveness of behavior modification intervention for patients with chronic kidney disease in the FROM-J study. J Ren Nutr. 2021;31:484–93.CrossRef
11.
Zurück zum Zitat Adang E, Voordijk L, Jan van der Wilt G, Ament A. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. Health Policy. 2005;74:146–56.CrossRef Adang E, Voordijk L, Jan van der Wilt G, Ament A. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. Health Policy. 2005;74:146–56.CrossRef
12.
Zurück zum Zitat Cohen J, Cairns C, Paquette C, Faden L. Comparing patient access to pharmaceuticals in the UK and US. Appl Health Econ Health Policy. 2006;5:177–87.CrossRef Cohen J, Cairns C, Paquette C, Faden L. Comparing patient access to pharmaceuticals in the UK and US. Appl Health Econ Health Policy. 2006;5:177–87.CrossRef
13.
Zurück zum Zitat Kondo M, Yamagata K, Hoshi SL, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18:885–91.CrossRef Kondo M, Yamagata K, Hoshi SL, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18:885–91.CrossRef
14.
Zurück zum Zitat Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices—budget impact analysis. Value Health. 2007;10:336–47.CrossRef Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices—budget impact analysis. Value Health. 2007;10:336–47.CrossRef
15.
Zurück zum Zitat Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17:5–14.CrossRef Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17:5–14.CrossRef
16.
Zurück zum Zitat Mauskopf J, Earnshaw SR, Brogan A, Wolowacz S, Brodtkorb T. Budget-impact analysis of health care interventions: a practical guide. Lausanne: ADIS; 2017.CrossRef Mauskopf J, Earnshaw SR, Brogan A, Wolowacz S, Brodtkorb T. Budget-impact analysis of health care interventions: a practical guide. Lausanne: ADIS; 2017.CrossRef
17.
Zurück zum Zitat Ministry of Health, Labour and Welfare Heisei 27 nendo tokutei kenko shinsatokutei hoken shidono jisshi jyokyo ni tsuite. Tokyo: Ministry of Health, Labour and Welfare; 2017. Ministry of Health, Labour and Welfare Heisei 27 nendo tokutei kenko shinsatokutei hoken shidono jisshi jyokyo ni tsuite. Tokyo: Ministry of Health, Labour and Welfare; 2017.
18.
Zurück zum Zitat Sugimoto K. Shinryou tensuu hayamihyo. Tokyo: Igaku Tsuusinsha; 2018. p. 2018. Sugimoto K. Shinryou tensuu hayamihyo. Tokyo: Igaku Tsuusinsha; 2018. p. 2018.
19.
Zurück zum Zitat Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of 31 December, 2019. Tokyo: Japanese Society for Dialysis Therapy Sugimoto K. Shinryou tensuu hayamihyo. Tokyo: Igaku Tsuusinsha; 2021. Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of 31 December, 2019. Tokyo: Japanese Society for Dialysis Therapy Sugimoto K. Shinryou tensuu hayamihyo. Tokyo: Igaku Tsuusinsha; 2021.
20.
Zurück zum Zitat Ministry of Health, Labour and Welfare estimations of national medical care expenditure 2018. [Accessed Aug 10, 2021]. Tokyo: Ministry of Health, Labour and Welfare; 2020. Ministry of Health, Labour and Welfare estimations of national medical care expenditure 2018. [Accessed Aug 10, 2021]. Tokyo: Ministry of Health, Labour and Welfare; 2020.
21.
Zurück zum Zitat Takemoto Y, Naganuma T. Economic issues of chronic kidney disease and end-stage renal disease. Contrib Nephrol. 2019;198:87–93.CrossRef Takemoto Y, Naganuma T. Economic issues of chronic kidney disease and end-stage renal disease. Contrib Nephrol. 2019;198:87–93.CrossRef
22.
Zurück zum Zitat Japanese association of dialysis physicians. Dai 24 kai touseki iryohi jittai tyosa hukoku (in Japanese). J Jpn Assoc Dial Phys. 2020;35:638–45. Japanese association of dialysis physicians. Dai 24 kai touseki iryohi jittai tyosa hukoku (in Japanese). J Jpn Assoc Dial Phys. 2020;35:638–45.
Metadaten
Titel
Behaviour modification intervention for patients with chronic kidney disease could provide a mid- to long-term reduction in public health care expenditure: budget impact analysis
verfasst von
Reiko Okubo
Masahide Kondo
Shu-Ling Hoshi
Hirayasu Kai
Chie Saito
Kunitoshi Iseki
Chiho Iseki
Tsuyoshi Watanabe
Ichiei Narita
Seiichi Matsuo
Hirofumi Makino
Akira Hishida
Kunihiro Yamagata
Publikationsdatum
27.01.2022
Verlag
Springer Nature Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 6/2022
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-022-02185-1

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.